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A B S T R A C T
Background: Pharmacoinvasive therapy (PIT) is feasible in patients with acute myocardial infarction 
with ST-segment elevation (STEMI) when timely primary percutaneous coronary intervention (PCI) is 
unavailable. In this study, we compared women who underwent successful reperfusion PIT with those who 
required rescue PCI, to identify potential predictors of thrombolytic failure. 
Methods: From January 2010 to November 2014, 327 consecutive women with STEMI were referred to a 
tertiary hospital, 206 after successful thrombolysis (63%) and 121 who required rescue PCI. The groups 
were compared regarding demographic, clinical and angiographic outcomes, and clinical (TIMI, GRACE, 
and ZWOLLE CADILLAC) and bleeding (CRUSADE) risk scores. A multivariate logistic regression model was 
used to identify predictors of thrombolytic failure.
Results: There was no significant difference between the demographic characteristics or the medical 
history of the groups. Rescue PCI group had significantly higher values of the evaluated scores. Clinical 
hospital complications and mortality (2.5% vs. 22.0%; p < 0.0001) were more frequent in rescue PCI group. 
The independent variables associated with rescue PCI were pain-to-needle time > 3h (OR: 3.07, 95%CI: 1.64 
to 5.75; p < 0.0001), ZWOLLE score (OR: 1.25; 95%CI: 1.14 to 1.37; p = 0.0001) and creatinine clearance (OR: 
1.009, 95%CI: 1.0 to 1.02; p = 0.04).
Conclusions: Women with STEMI who underwent PIT and who required rescue PCI had significantly higher 
mortality compared to those who achieved initial success of PIT with elective PCI. Pain-to-needle time > 
3h, ZWOLLE score and creatinine clearance were independent predictors of the need for rescue PCI.
© 2015 Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista. Published by Elsevier Editora Ltda. 
This is an open access article under the CC BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/4.0/). 
 
Fatores preditivos de intervenção coronária percutânea de resgate após 
estratégia fármaco-invasiva em mulheres
R E S U M O
Introdução: A estratégia fármaco-invasiva (EFI) é viável em pacientes com infarto agudo do miocárdio com 
supradesnivelamento do segmento ST (IAMCST), quando a intervenção coronária percutânea (ICP) primária 
em tempo hábil não é possível. Neste estudo, comparamos mulheres submetidas à EFI com sucesso para 
reperfusão àquelas que necessitaram de ICP de resgate, para identificar possíveis preditores de insucesso 
do trombolítico.
Métodos: De janeiro de 2010 a novembro de 2014, 327 mulheres com IAMCST e EFI foram encaminhadas ao 
hospital terciário, sendo 206 após trombólise com sucesso (63%) e 121 que necessitaram de ICP de resgate. 
Os grupos foram comparados quanto a variáveis demográficas, desfechos clínicos e angiográficos, e escores 
de risco clínico (TIMI, GRACE, ZWOLLE e CADILLAC) e de sangramento (CRUSADE). Um modelo de regressão 
logística multivariada foi utilizado para identificar preditores de insucesso do trombolítico.
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Introduction
Although primary percutaneous coronary intervention (PCI) is 
the gold standard for patients with ST-segment elevation acute myo-
cardial infarction (STEMI), low availability still prevents its broad 
use, as recommended by the most contemporary guidelines.1,2 
Therefore, pharmacoinvasive therapy (PIT) has shown to be a feasi-
ble and valuable option in terms of public health, with efficacy re-
sults similar to those of primary PCI in several studies, and in 
national and international registries.3-5 In brief, PIT is the rapid ap-
plication of a fibrin-specific thrombolytic therapy in primary care, 
followed by transfer to cardiac catheterization in 3-24 h and perfor-
mance of PCI in the culprit artery, if applicable. However, its weak 
point is thrombolytic therapy failure in one-third of cases. In the 
STREAM randomized trial,4 which compared PIT with primary PCI in 
almost 1,900 patients, rescue PCI occurred in 36% of cases.
STEMI is the leading cause of death among Western women and 
is already a leading cause of death among women in Brazil.6,7 The 
authors recently analyzed mortality data and major cardiac events 
in women with STEMI submitted to PIT and observed mortality rates 
twice as high as those observed in men.8 However, in the multivari-
ate analysis, gender was not a risk factor in itself, but rather the fact 
that women presented more risk factors.
The present analysis compared women with STEMI submitted to 
PIT who achieved successful lytic reperfusion with women who re-
quired rescue PCI, identifying possible predictors of thrombolytic 
therapy failure.
Methods
From January 2010 to November 2014, 1,261 patients were pro-
spectively included in the Sao Paulo ST-Segment Elevation Myocar-
dial Infarction (STEMI) Registry, as specif ied in a previously 
published protocol3 and also in clinicaltrials.org NCT 02090712. In 
this registry, patients with STEMI were treated with up to 12 h of 
evolution using preferably primary PCI, but performing PIT if PCI 
was not available. Of these, 327 women (26% of the cohort) were 
treated with PIT and early elective catheterization (PIT, n = 206) or 
rescue PCI after failed thrombolysis (rescue PCI, n = 121). PIT success 
was defined as systematic cardiac catheterization and elective PCI, if 
necessary, performed 3 to 24 hours after thrombolytic use. The cri-
teria to define reperfusion failure were persistent chest pain in pre-
thrombolysis levels, and persistent ST-segment elevation > 50% of 
the original elevation or early relapse or symptom worsening, with 
or without hemodynamic instability. These two groups were com-
pared for demographic variables, clinical outcomes (mortality at 
catheterization and in-hospital mortality), pain-to-needle and door-
to-needle time, risk scores (TIMI, GRACE, ZWOLLE, CADILLAC),9,10 
risk of bleeding (CRUSADE),11 and complications such as congestive 
heart failure (CHF), cardiogenic shock, total atrioventricular block 
(TAVB), major and minor bleeding, and stroke. Left ventricular ejec-
tion fraction was obtained in the echocardiographic assessment per-
formed within the first 48 hours.
Definitions
Thrombolysis in Myocardial Infarction (TIMI) flow and myocar-
dial blush were assessed as previously reported12,13 Creatinine clear-
ance was estimated according to the Cockcroft-Gault formula.14 
Renal failure was defined as the presence of creatinine clearance 
estimated at < 60 mL/min. Bleeding severity was established accord-
ing to the Bleeding Academic Research Consortium (BARC) criteria.15 
Patients considered as having major bleeding were those with BARC 
≥ 3; minor bleeding, those with BARC < 3. Death during catheteriza-
tion was defined as death that occurred in the hemodynamics labo-
ratory, during the index procedure.
Statistical analysis
Data were prospectively stored in an ExcelTM spreadsheet (Micro-
soft Corporation, Redmond, USA) and submitted to statistical analy-
sis using Statistical Package for Social Science (SPSS), version 22.0. 
Continuous variables were expressed as means and standard devia-
tions, and categorical variables as absolute numbers and percentag-
es. Categorical variables were compared using Pearson’s chi-squared 
test, while numerical variables with normal distribution were com-
pared using Student’s t-test or the Mann-Whitney test, when appli-
cable. Moreover, stepwise logistic regression was performed to 
evaluate independent predictors of rescue PCI. Statistically signifi-
cant variables in the univariate analysis were included in the regres-
sion, in addition to those considered important as rescue PCI 
predictors, such as pain-to-needle and door-to-needle time. Interac-
tions between the several risk scores, age, and renal failure were cor-
rected. P-values < 0.05 were considered as statistically significant.
Results
The rate of need for rescue PCI in this analysis was 37.0%. Age in 
the overall group ranged from 24 to 86 years, with a mean of 59.9 ± 
11.9 years. There were no significant differences in any demographic 
variable or clinical history between the two groups (Table 1).
On admission, mean blood pressure and heart rate (76.5 ± 15 bpm 
vs. 78 ± 21 bpm; p = 0.36) were similar; however, patients from the 
rescue PCI group showed lower systolic blood pressure (132.8 ± 24.6 
mmHg vs. 126 ± 31 mmHg, p = 0.03). Mean door-to-needle time (1.9 
± 2.0 hours vs. 2.0 ± 3.0 hours; p = 0.82) and pain-to-needle time (8.3 
± 13.6 hours vs. 7.9 ± 16.7 hours, p = 0.85) were also the same in both 
groups. Mean time between the onset of thrombolysis and coronary 
Resultados: Não houve diferença significativa entre as características demográficas ou os antecedentes 
clínicos dos grupos. O grupo ICP de resgate apresentou valores significantemente maiores dos escores 
avaliados. Complicações clínicas hospitalares e mortalidade (2,5% vs. 22,0%; p < 0,0001) foram mais 
frequentes no grupo ICP de resgate. As variáveis independentes associadas à ICP de resgate foram tempo 
dor-agulha > 3 horas (OR 3,07; IC95% 1,64-5,75; p < 0,0001), escore ZWOLLE (OR 1,25; IC95% 1,14-1,37; p = 
0,0001) e clearance de creatinina (OR 1,009; IC95% 1,0-1,02; p = 0,04).
Conclusões: Mulheres com IAMCST submetidas à EFI e que necessitaram de ICP de resgate tiveram 
mortalidade significativamente maior quando comparadas àquelas que obtiveram sucesso inicial da EFI 
com ICP eletiva. Tempo dor-agulha > 3 horas, escore de ZWOLLE e clearance de creatinina foram preditores 
independentes da necessidade de ICP de resgate.
© 2015 Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista. Publicado por Elsevier Editora Ltda. 
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angiography was 18.6 ± 17.0 hours in PIT group vs. 7.3 ± 6.5 hours in 
the rescue PCI group (p < 0.001).
Regarding the mortality risk scores (TIMI, GRACE, ZWOLLE and 
CADILLAC) or bleeding score (CRUSADE), significantly higher values 
were observed in the rescue PCI group (Table 2).
The mean left ventricular ejection fraction was 53.0 ± 11.5% in the 
PIT group vs. 47.4 ± 10.7% in the rescue PCI group (p < 0.0001). As for 
the distribution of culprit arteries, no significant difference was 
found in the incidence of lesions occurring in the territory of the left 
anterior descending artery (31% vs. 42.5%), left circumflex artery 
(11% vs. 6.5%), or right coronary artery (52% vs. 39%) between the PIT 
and rescue PCI groups, respectively (p = 0.35).
During the in-hospital evolution, severe complications of AMI 
were significantly more frequent in patients from the rescue PCI 
group (Table 3). Only one patient in each group had a hemorrhagic 
stroke.
Table 4 shows the initial and final flow angiographic variables, 
demonstrating a significant reduction in procedural success in the 
rescue PCI group (reduction in TIMI 2 or 3 frequency at the end of the 
procedure and of myocardial blush flow 2 or 3).
In-hospital mortality (all-cause) occurred in 2.5% of the PIT group 
and in 22% of the rescue PCI group (p < 0.0001), with a trend for high-
er mortality related to catheterization.
Independent variables associated with the need for rescue PCI 
were pain-to-needle time > 3 hours, with an odds ratio of 3.07 
(95%CI: 1.645–5.751; p < 0.0001), ZWOLLE score, with an odds ratio 
of 1.25 (95%CI: 1.139–1.370; p = 0.0001), and creatinine clearance, 
with an odds ratio of 1.009 (95%CI: 1.0–1.019; p = 0.04).
Discussion
This study, which included 327 women submitted to PIT, showed 
that the population in need of rescue PCI had a higher number of 
adverse events and significantly higher number of deaths than the 
population submitted to clinically successful PIT. Although these 
data are known in overall post-thrombolysis treatment, this is one of 
the first reports in a population submitted to PIT, confirming that 
the results can be superimposed to those of the population treated 
without PIT.
The low representation of women in several studies on coronary 
artery disease hinders the use of conclusions obtained from these 
studies in the treatment of this important segment of the popula-
tion. Therefore, the analysis of large registries, such as the present, 
which included all patients receiving treatment after clinical indica-
tion (all-comers), helps make better use of resources and treatments, 
as well as understanding possible treatment failure mechanisms.
Although widely known as a population at high risk of death dur-
ing STEMI, when adjusted for age and comorbidities, the importance 
of the female gender as a risk factor for mortality is still debatable.16 
The risk reduction provided by thrombolysis in women with STEMI 
is also lower than in men,17,18 which may be due to older age at pre-
sentation, delay in seeking medical care and the emergency room, 
and more difficult diagnosis when compared to men.19
The present study’s rate for rescue PCI was 37%. In the STREAM 
trial, the most important comparison study between PIT and prima-
ry PCI, 1,892 patients were randomized with up to 3 hours after myo-
cardial infarction onset. For the combined endpoint of death/shock/
CHF or reinfarction at 30 days, the groups had similar results. In that 
study, although with much shorter time until treatment than the 
present study, the rate for rescue PCI was 36.3%. In the NCDRTM regis-
try, 41.5% of patients receiving fibrinolysis required rescue PCI.20 
With transfer times that remain long between the primary hospi-
tal and the tertiary center, which are characteristic of the authors’ 
experience, the present study’s rescue PCI rate might include possi-
ble cases of early reocclusion. However, of more concern is the pos-
sibility that this similarity in the need for rescue PCI among this 
population and that in literature represents a diagnostic underesti-
mation that must be explored.
In general, as shown above, the present study’s rate of bleeding/
vascular complications is low and comparable to that in literature 
(4.6%),21 especially when considering the procedures performed via 
femoral artery only. Similar to other experiences, the present popu-
lation had a moderate risk of bleeding based on the CRUSADE score 
and the frequency of bleeding was correctly predicted.22 However, 
this score has not been adequately tested for this scenario (PIT and 
Table 1
Demographic and clinical data.
Variable
PIT  
(n = 206)
Rescue PCI  
(n = 121) p-value
Age, years 59.6 ± 11.5 60.4 ± 12.6 0.52
Body mass index, kg/m2 26.3 ± 4.9 26.7 ± 5.5 0.44
Diabetes mellitus, n (%) 74 (35.9) 45 (37.2) 0.81
Arterial hypertension, n (%) 145 (70.4) 88 (73.3) 0.57
Dyslipidemia, n (%) 128 (62.4) 82 (68.3) 0.28
Smoking, n (%) 129 (63.2) 74 (61.7) 0.77
Family history of CAD, n (%) 58 (28.2) 35 (29.2) 0.84
Previous myocardial infarction, n (%) 17 (8.3) 12 (10.0) 0.59
Previous stroke, n (%) 12 (5.8) 7 (5.8) 0.99
Previous CABG, n (%) 7 (3.4) 3 (2.5) 0.38
Obesity, n (%) 50 (24.3) 32 (26.7) 0.63
Alcohol consumption, n (%) 9 (4.4) 6 (5.0) 0.80
Peripheral vascular disease, n (%) 10 (4.9) 11 (9.2) 0.12
Chronic renal failure, n (%) 23 (11.2) 17 (14.0) 0.44
PIT: pharmacoinvasive therapy; PCI: percutaneous coronary intervention; CAD: coronary artery dis-
ease; CABG: coronary artery bypass graft.
Table 2
Comparison of mean values of risk scores between groups.
Variable
PIT 
(n = 206)
Rescue PCI 
(n = 121)   p-value
TIMI score 3.8 ± 2.2 5.2 ± 2.3 < 0.0001
GRACE score 142 ± 32 171 ± 48.6 < 0.0001
ZWOLLE score 3.4 ± 3 6.6 ± 4.8 < 0.0001
CADILLAC score 3.2 ± 2.8 4.5 ± 3.7 0.003
CRUSADE score 33.3 ± 13 37.8 ± 14.1 0.004
PIT: pharmacoinvasive therapy; PCI: percutaneous coronary intervention.
Table 3
In-hospital clinical evolution.
Outcome
PIT  
(n = 206)
Rescue PCI  
(n = 121) p-value
In-hospital death, n (%) 5 (2.4) 27 (22.3) < 0.0001
Death during catheterization, n (%) 2 (1.0) 5 (4.1) 0.06
CHF, n (%) 35 (17.0) 60 (49.6) < 0.0001
Cardiogenic shock, n (%) 8 (3.9) 34 (28.3) < 0.0001
Total atrioventricular block, n (%) 7 (3.4) 22 (18.2) < 0.0001
Intra-aortic balloon, n (%) 4 (1.9) 25 (20.7) < 0.0001
Major bleeding, n (%) 5 (2.4) 10 (8.3) 0.02
Minor bleeding, n (%) 9 (4.4) 3 (2.5) 0.38
PIT: pharmacoinvasive therapy; PCI: percutaneous coronary intervention; CHF: congestive heart 
failure.
Table 4
Comparison of TIMI flow and myocardial blush pre- and post-percutaneous coronary 
intervention (PCI).
Variable
PIT 
(n = 206)
Rescue PCI  
(n = 121) p-value
TIMI pre-PCI 0 or 1, n (%) 28 (13.9) 68 (56.7) < 0.0001
TIMI post-PCI 2 or 3, n (%) 183 (92.9) 100 (85.5) < 0.03
Blush pre-PCI 0 or 1, n (%) 55 (27.2) 85 (70.8) < 0.0001
Blush post-PCI 2 or 3, n (%) 168 (85.3) 62 (53) < 0.0001
PIT: pharmacoinvasive therapy.
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rescue PCI). The higher frequency of major bleeding in the rescue PCI 
group (2.4% vs. 8.3%) may be secondary to multiple mechanisms, 
such as earlier catheterization, longer and more complex proce-
dures, or more frequent use of antithrombotic drugs (data not re-
ported here). The similar frequency of major bleeding when 
comparing primary PCI and PIT has already been established,4 but 
the increased risk associated with the need for rescue PCI has been 
reported in another large registry, reaching 13%.20
In a previous publication from the authors’ experience, with a 
population of 469 patients, including 140 women, female patients 
showed higher mortality than males (9.3% vs. 4.9%; p = 0.07), but 
gender was not a predictor of death or major adverse events in the 
multivariate analysis, with the difference in the incidence of death 
due to more frequent comorbidities in women.8 In the present study, 
it was observed that the group undergoing thrombolysis without 
success and submitted to rescue PCI had a demographic and clinical 
profile similar to that of women with clinically successful reperfu-
sion. Both groups were characterized by the high frequency of 
known risk markers, such as diabetes, renal failure, and previous 
coronary heart disease (infarction or myocardial revascularization). 
The present population also had a higher risk profile than that in 
literature.4,23 In the authors’ overall experience, including both gen-
ders, total mortality for PIT is approximately 6%,8,24 and was 9.7% in 
the group of women included here. Mortality rates below 5% were 
observed in the STREAM and in the CAPTIM studies, which random-
ized patients with up to 3 hours and 6 hours of evolution, respec-
tively.4,23 Particularly in the PIT group, consisting only of women 
with successful thrombolysis and early PCI, a mortality rate of 2.5% 
was observed, which reinforces this approach for a large portion of 
these patients. Associated with the finding of ischemia time longer 
than 3 hours as an independent predictor of reperfusion failure (OR: 
3.07, 95%CI: 1.645 - 5.751; p < 0.0001), it also demonstrates the need 
for policies directed at the early use of thrombolytic agents, prefer-
ably in the emergency units, outpatient clinics, or pre-hospital ad-
mission emergency rooms or ambulances, because by increasing the 
rates of successful lytic reperfusion and preserving viable myocar-
dium, surely there will be a decrease in mortality.
In addition to time of ischemia and presence of renal dysfunction, 
the latter a known predictor of mortality and complications in car-
diovascular disease, the ZWOLLE score was a predictor of rescue PCI. 
The finding of higher risk scores in women compared to men is well 
known.8,25 The ZWOLLE score, a validated scoring system for identi-
fying low-risk patients after primary PCI who would be eligible for 
early discharge,9 was a predictor of unsuccessful thrombolysis in the 
group of female individuals. As one of the score components in-
cludes time of ischemia, perhaps this was the main score component 
that influenced its importance in this population. It is considered 
that patients with scores ≤ 3 would be subject to early discharge af-
ter primary PCI; even considering a high-risk population, as shown 
here, the PIT group score was very close to this value, suggesting 
that this index also deserves validation in the group of post-throm-
bolysis patients.
Unlike the international experience of randomized studies,1,2 this 
registry still observed that the pain-to-needle and door-to-needle 
times were high and represented a significant limitation for further 
improvement of results. However, they were also the expression of 
the public health care reality in a large urban city in Brazil.
Indicators of reperfusion after thrombolytic therapy are not low-
er in female than in male patients. In a large angiographic review of 
patients enrolled in four studies of the TIMI group, including 2,596 
patients, the degree of myocardial perfusion (blush) and the cor-
rected TIMI frame count were similar between the genders25 after 
thrombolysis and after PCI. The authors concluded that differences 
in reperfusion did not account for the difference in mortality. In the 
present study, 71% of patients with rescue PCI showed initial blush of 
0 or 1 (consistent with a diagnosis of unsuccessful thrombolysis) and 
in 47%, this abnormal flow was maintained after PCI, although the 
rate of TIMI 2 or 3 and the absence of residual lesion (successful PCI) 
were present in 85.5%. In those receiving late treatment, such as the 
present patients, the rate of inadequate reperfusion was, therefore, 
higher and more evident.
Limitations
As in any retrospective analysis, the data were subject to varying 
confounders, which can alter the results. The differences regarding 
patterns of medication use were not analyzed, which could certainly 
affect reperfusion results. No detailed data on the angiographic 
analysis, location, and complexity of the culprit lesion were supplied 
in this publication.
Conclusions
This study demonstrated that female patients submitted to res-
cue percutaneous coronary intervention showed high frequency of 
heart failure and cardiogenic shock, and that bleeding rates were 
higher than those observed in the overall population. The degree of 
myocardial perfusion (blush) was significantly reduced in patients 
after rescue percutaneous coronary intervention. As previously 
demonstrated by this group, the occurrence of inadequate reperfu-
sion is an important predictor of death and, here, it may have been 
determinant of mortality rates in the percutaneous coronary inter-
vention rescue group, which was almost ten-fold higher than the 
mortality rate observed in the successful pharmacoinvasive therapy 
group. It is speculated that this inadequate reperfusion may be re-
lated to long pain-to-needle time and pain-to-rescue PCI time.
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